RN7SL294P

Across TCGA pan-cancer cohorts, RN7SL294P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RN7SL294P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SL294P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL294P expression acts as an unfavorable survival marker.

KIRC, PAAD, and PCPG are the cancer types where RN7SL294P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.198	0.796	.005	54	view →
PAAD	DFS	Tertile	All	0.068	0.468	<.001	36	view →
PCPG	OS	Tertile	All	0.078	0.955	<.001	36	view →
UCEC	OS	Tertile	All	0.179	0.689	<.001	36	view →
ESCA	OS	Tertile	II,III,IV	0.164	0.687	.007	18	view →
HNSC	DFS	Tertile	IV	0.163	0.669	.033	18	view →
SARC	OS	Tertile	All	0.029	0.828	<.001	18	view →
LAML	DFS	Tertile	All	0.028	0.583	.001	18	view →
LUSC	DFS	Tertile	II,III,IV	0.139	0.663	.027	18	view →
STAD	OS	Tertile	II,III,IV	0.464	0.669	.041	15	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RN7SL294P–KIRC (DFS)

Open the KIRC breakdown →